세계의 의약 좌제 시장 : 유형별, 기제별, 처방 유형별, 치료 용도별, 충전량 카테고리별, 연령층별, 유통 채널별, 최종 사용자별 - 기회 분석과 산업 예측(2024-2035년)

Pharmaceutical Suppositories Market By Type, By Base, By Prescription Type, By Therapeutic Application, By Fill Volume Categories, By Age Group, By Distribution Channel, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035

US $ 4,425 ￦ 6,152,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,304,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세계의 의약 좌제 시장은 2023년 16억 6,809만 달러, 2035년까지는 32억 3,932만 달러에 이르고, 2024년부터 2035년까지 CAGR은 5.7%에 이를 것으로 추정됩니다.

의약 좌제은 체강 내로 삽입하도록 고안된 고형 제형으로, 용해 또는 용융하여 활성 성분을 방출합니다. 일반적으로 코코아 버터, 글리세린 젤라틴, 폴리에틸렌 글리콜(PEG)과 같은 기판을 사용하여 제형화되어 안정성을 제공하고 약물 방출을 제어할 수 있습니다. 제조 공정에서는 기제를 녹이고, 약제 활성 성분(API) 및 필요한 부형제와 혼합하고, 혼합물을 원하는 형상으로 성형합니다. 냉각 후, 좌제는 응고하고 사용하기 위해 포장됩니다. 좌약은 점막 흡수에 의해 약물을 전달하도록 설계되었습니다.

의약 좌제 시장은 몇 가지 중요한 요인에 의해 성장하고 있습니다. 노인들은 태블릿을 삼키는 데 어려움을 겪거나 국부적인 약물 전달이 필요하기 때문입니다. 또한 위장 장애와 특정 암 등 만성 질환의 유병률이 상승하고 있기 때문에 좌약이 제공할 수 있는 표적 치료의 요구가 높아지고 있습니다. 약물 전달의 추가 진보로 좌약으로 투여되는 약물의 범위가 확대되고 그 효과가 높아지고 있습니다. 예를 들어, 2023년에 National Library of Medicine이 발표한 연구는 직장으로 투여된 아지트로마이신 좌제가 소아 집단에서 경구 투여에 비해 생체이용률이 유의하게 증가한 것으로 나타났습니다. 또한 조기진단을 촉진하는 정부의 이니셔티브와 좌약의 장점에 대한 일반 시민의 인식을 높이기 위한 제약회사의 노력이 시장의 성장을 더욱 추진하고 있습니다.

그러나 시장 확대를 방해하는 과제도 있습니다. 용해성 문제로 인해 모든 약물이 좌약을 통해 안정적으로 또는 효과적으로 전달되는 것은 아니므로 약물의 적합성이 제한되어 있다는 것이 여전히 문제가 되고 있습니다. 게다가 복잡한 제조 공정에는 특수 장비가 필요하기 때문에 제조 비용이 상승하고 제조업체의 수가 제한됩니다. 이러한 요인은 시장에 대한 액세스를 제한하고 비용이 많이 들고 전반적인 가치감에 영향을 미칩니다. 이러한 과제에도 불구하고, 좌약 수요는 약물 전달의 독특한 이점을 뒷받침하여 상승을 계속하고 있습니다.

의약 좌제 시장은 유형, 기제, 처방 유형, 치료 용도, 충전량 카테고리, 연령대, 성분 유형, 유통 채널, 지역으로 구분됩니다. 유형별로 시장은 직장좌약, 질좌약, 요도좌약으로 나뉩니다. 기제별로는 지방성 기제, 수혼화성 기제, 유화성 기제로 분류됩니다. 수혼화성 기제는 또한 글리세로젤라틴 기제, 비누 글리세린 좌제, 폴리에틸렌 글리콜 기제로 구분됩니다. 유화성 기제는 또한 위테프졸, 마사에스테륨, 마사폴로 구분됩니다. 처방 유형에 따라 OTC 좌약과 처방 좌약으로 이분됩니다. 치료 용도 기반은 진통, 항염증제, 제토약, 완하제, 호르몬 요법, 항진균 및 항균제 등으로 분류됩니다. 충전량의 카테고리별로는 작은 충전량, 중충전량, 대충전량으로 나눌 수 있습니다. 연령층별로는 소아용과 성인용으로 나눌 수 있습니다. 성분 유형에 따라 원료와 부형제로 분류됩니다. 유통 채널별로는 병원 약국, 소매 약국, 온라인 판매로 나뉩니다. 최종 사용자별로는 병원 및 진료소, 재택치료, 기타로 분류됩니다. 지역별로 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분류됩니다.

이해관계자를 위한 주요 이점

• 본 보고서에서는 2023년부터 2035년까지의 의약 좌제 시장 분석 시장 부문, 현재의 동향, 추정·역학을 정량적으로 분석하여 의약 좌제 시장의 유력한 기회를 특정합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해관계자들이 이익에 중점을 둔 비즈니스 결정을 내리고 공급업체와 구매자의 네트워크를 강화할 수 있도록 구매자와 공급업체의 힘을 강조합니다.
• 의약 좌제 시장의 세분화에 대한 자세한 분석은 시장 기회를 결정하는 데 도움이 됩니다.
• 각 지역의 주요 국가는 세계 시장에 대한 수익 공헌도에 따라 매핑됩니다.
• 시장 기업 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계 의약 좌제 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략의 분석이 포함되어 있습니다.

이 보고서에서 가능한 맞춤설정(추가 비용 및 일정 필요)

• 고객의 관심에 따른 기업 프로파일 추가
• 기업 프로파일의 확장 목록
• 과거 시장 데이터
• 수출입 분석/데이터

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
    • 급성 및 만성질환의 유병률 상승
    • 고령자 인구 증가
    • 좌약의 사용에 관한 인식과 교육에 대한 대처 증가
  • 억제요인
    • 의약 좌제 제조의 복잡성
    • 좌약의 보관과 안정성의 문제
  • 기회
    • 제제기술의 진보

제4장 의약 좌제 시장 : 유형별

• 개요
• 직장 좌제
• 질 좌제

제5장 의약 좌제 시장 : 기제별

• 개요
• 지방염기
• 수혼화성 기제
  • 수혼화성 기제의 의약 좌제 시장 : 유형별
• 유화성 기제
  • 유화성 기제의 의약 좌제 시장 : 유형별

제6장 의약 좌제 시장 : 처방 유형별

• 개요
• 일반용 의약품
• 처방 좌제

제7장 의약 좌제 시장 : 치료 용도별

• 개요
• 진통제·항염증약
• 제토제
• 완하제
• 호르몬 요법
• 항진균제·항균제
• 기타

제8장 의약 좌제 시장 : 충전량 카테고리별

• 개요
• 소용량 충전제
• 중용량 충전제
• 대용량 충전제

제9장 의약 좌제 시장 : 연령층별

• 개요
• 소아용
• 성인용

제10장 의약 좌제 시장 : 유통 채널별

• 개요
• 병원 약국
• 약국·소매 약국
• 온라인 제공업체

제11장 의약 좌제 시장 : 최종 사용자별

• 개요
• 병원 및 진료소
• 재택치료
• 기타

제12장 의약 좌제 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 기타
• 라틴아메리카
  • 라틴아메리카
  • 중동 및 아프리카

제13장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2023년

제14장 기업 프로파일

• Intas Pharmaceuticals Ltd.
• Pfizer Inc.
• Church & Dwight Co. Inc.
• Zydus Lifesciences Limited
• Bayer AG
• Novartis AG
• Sanofi SA
• Bliss GVS Pharma Ltd
• Bausch Health Companies Inc.
• Cosette Pharmaceuticals, Inc.

JHS

영문 목차

영문목차

The pharmaceutical suppositories market was valued for $1,668.09 million in 2023 and is estimated to reach $3,239.32 million by 2035, exhibiting a CAGR of 5.7% from 2024 to 2035.

Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.

The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness. For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies' efforts to raise public awareness of suppository benefits, further support market growth.

However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.

The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use. Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2023 to 2035 to identify the prevailing pharmaceutical suppositories market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Additional company profiles with specific to client's interest
• Expanded list for Company Profiles
• Historic market data
• Import Export Analysis/Data

Key Market Segments

By Prescription Type

• OTC
• Prescribed Suppositories

By Therapeutic Application

• Analgesics and Anti-Inflammatory Drugs
• Antiemetics
• Laxatives
• Hormonal Therapies
• Antifungals and Antibacterials
• Others

By Fill Volume Categories

• Small Fill Volumes
• Medium Fill Volumes
• Large Fill Volumes

By Type

• Rectal Suppositories
• Vaginal Suppositories

By Age Group

• Pediatric Use
• Adult Use

By Base

• Fatty Bases
• Water Miscible Base
  • Type
  • Glycero Gelatin Base
  • Soap Glycerin Suppositories
  • Polyethylene Glycol Bases
• Emulsifying Bases
  • Type
  • Witepsol
  • Massa Esterium
  • Massuppol

By Distribution Channel

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Providers

By End User

• Hospitals and Clinics
• Home Care
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
• LAMEA
  • Latin America
  • Middle East And Africa

Key Market Players:

• Bausch Health Companies Inc.
• Bayer AG
• Bliss GVS Pharma Ltd
• Church & Dwight Co. Inc.
• Cosette Pharmaceuticals, Inc.
• Intas Pharmaceuticals Ltd.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Zydus Lifesciences Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Moderate bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. Moderate threat of substitutes
  • 3.3.4. Moderate intensity of rivalry
  • 3.3.5. Moderate bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of acute & chronic disorders
    • 3.4.1.2. Increase in the geriatric population
    • 3.4.1.3. Increase in initiatives for awareness and education for use of suppositories
  • 3.4.2. Restraints
    • 3.4.2.1. Manufacturing complexities of pharmaceutical suppositories
    • 3.4.2.2. Storage and stability issues of pharmaceutical suppositories
  • 3.4.3. Opportunities
    • 3.4.3.1. Technological advancements in formulation technology

CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Rectal Suppositories
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Vaginal Suppositories
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Fatty Bases
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Water Miscible Base
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
  • 5.3.4. Water Miscible Base Pharmaceutical Suppositories Market by Type
• 5.4. Emulsifying Bases
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
  • 5.4.4. Emulsifying Bases Pharmaceutical Suppositories Market by Type

CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. OTC
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Prescribed Suppositories
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country

CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION

• 7.1. Overview
  • 7.1.1. Market size and forecast
• 7.2. Analgesics and Anti-Inflammatory Drugs
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by region
  • 7.2.3. Market share analysis by country
• 7.3. Antiemetics
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by region
  • 7.3.3. Market share analysis by country
• 7.4. Laxatives
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by region
  • 7.4.3. Market share analysis by country
• 7.5. Hormonal Therapies
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by region
  • 7.5.3. Market share analysis by country
• 7.6. Antifungals and Antibacterials
  • 7.6.1. Key market trends, growth factors and opportunities
  • 7.6.2. Market size and forecast, by region
  • 7.6.3. Market share analysis by country
• 7.7. Others
  • 7.7.1. Key market trends, growth factors and opportunities
  • 7.7.2. Market size and forecast, by region
  • 7.7.3. Market share analysis by country

CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES

• 8.1. Overview
  • 8.1.1. Market size and forecast
• 8.2. Small Fill Volumes
  • 8.2.1. Key market trends, growth factors and opportunities
  • 8.2.2. Market size and forecast, by region
  • 8.2.3. Market share analysis by country
• 8.3. Medium Fill Volumes
  • 8.3.1. Key market trends, growth factors and opportunities
  • 8.3.2. Market size and forecast, by region
  • 8.3.3. Market share analysis by country
• 8.4. Large Fill Volumes
  • 8.4.1. Key market trends, growth factors and opportunities
  • 8.4.2. Market size and forecast, by region
  • 8.4.3. Market share analysis by country

CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP

• 9.1. Overview
  • 9.1.1. Market size and forecast
• 9.2. Pediatric Use
  • 9.2.1. Key market trends, growth factors and opportunities
  • 9.2.2. Market size and forecast, by region
  • 9.2.3. Market share analysis by country
• 9.3. Adult Use
  • 9.3.1. Key market trends, growth factors and opportunities
  • 9.3.2. Market size and forecast, by region
  • 9.3.3. Market share analysis by country

CHAPTER 10: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL

• 10.1. Overview
  • 10.1.1. Market size and forecast
• 10.2. Hospital Pharmacies
  • 10.2.1. Key market trends, growth factors and opportunities
  • 10.2.2. Market size and forecast, by region
  • 10.2.3. Market share analysis by country
• 10.3. Drug Stores and Retail Pharmacies
  • 10.3.1. Key market trends, growth factors and opportunities
  • 10.3.2. Market size and forecast, by region
  • 10.3.3. Market share analysis by country
• 10.4. Online Providers
  • 10.4.1. Key market trends, growth factors and opportunities
  • 10.4.2. Market size and forecast, by region
  • 10.4.3. Market share analysis by country

CHAPTER 11: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER

• 11.1. Overview
  • 11.1.1. Market size and forecast
• 11.2. Hospitals and Clinics
  • 11.2.1. Key market trends, growth factors and opportunities
  • 11.2.2. Market size and forecast, by region
  • 11.2.3. Market share analysis by country
• 11.3. Home Care
  • 11.3.1. Key market trends, growth factors and opportunities
  • 11.3.2. Market size and forecast, by region
  • 11.3.3. Market share analysis by country
• 11.4. Others
  • 11.4.1. Key market trends, growth factors and opportunities
  • 11.4.2. Market size and forecast, by region
  • 11.4.3. Market share analysis by country

CHAPTER 12: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION

• 12.1. Overview
  • 12.1.1. Market size and forecast By Region
• 12.2. North America
  • 12.2.1. Key market trends, growth factors and opportunities
  • 12.2.2. Market size and forecast, by Type
  • 12.2.3. Market size and forecast, by Base
  • 12.2.4. Market size and forecast, by Prescription Type
  • 12.2.5. Market size and forecast, by Therapeutic Application
  • 12.2.6. Market size and forecast, by Fill Volume Categories
  • 12.2.7. Market size and forecast, by Age Group
  • 12.2.8. Market size and forecast, by Distribution Channel
  • 12.2.9. Market size and forecast, by End User
  • 12.2.10. Market size and forecast, by country
    • 12.2.10.1. U.S.
    • 12.2.10.1.1. Market size and forecast, by Type
    • 12.2.10.1.2. Market size and forecast, by Base
    • 12.2.10.1.3. Market size and forecast, by Prescription Type
    • 12.2.10.1.4. Market size and forecast, by Therapeutic Application
    • 12.2.10.1.5. Market size and forecast, by Fill Volume Categories
    • 12.2.10.1.6. Market size and forecast, by Age Group
    • 12.2.10.1.7. Market size and forecast, by Distribution Channel
    • 12.2.10.1.8. Market size and forecast, by End User
    • 12.2.10.2. Canada
    • 12.2.10.2.1. Market size and forecast, by Type
    • 12.2.10.2.2. Market size and forecast, by Base
    • 12.2.10.2.3. Market size and forecast, by Prescription Type
    • 12.2.10.2.4. Market size and forecast, by Therapeutic Application
    • 12.2.10.2.5. Market size and forecast, by Fill Volume Categories
    • 12.2.10.2.6. Market size and forecast, by Age Group
    • 12.2.10.2.7. Market size and forecast, by Distribution Channel
    • 12.2.10.2.8. Market size and forecast, by End User
    • 12.2.10.3. Mexico
    • 12.2.10.3.1. Market size and forecast, by Type
    • 12.2.10.3.2. Market size and forecast, by Base
    • 12.2.10.3.3. Market size and forecast, by Prescription Type
    • 12.2.10.3.4. Market size and forecast, by Therapeutic Application
    • 12.2.10.3.5. Market size and forecast, by Fill Volume Categories
    • 12.2.10.3.6. Market size and forecast, by Age Group
    • 12.2.10.3.7. Market size and forecast, by Distribution Channel
    • 12.2.10.3.8. Market size and forecast, by End User
• 12.3. Europe
  • 12.3.1. Key market trends, growth factors and opportunities
  • 12.3.2. Market size and forecast, by Type
  • 12.3.3. Market size and forecast, by Base
  • 12.3.4. Market size and forecast, by Prescription Type
  • 12.3.5. Market size and forecast, by Therapeutic Application
  • 12.3.6. Market size and forecast, by Fill Volume Categories
  • 12.3.7. Market size and forecast, by Age Group
  • 12.3.8. Market size and forecast, by Distribution Channel
  • 12.3.9. Market size and forecast, by End User
  • 12.3.10. Market size and forecast, by country
    • 12.3.10.1. Germany
    • 12.3.10.1.1. Market size and forecast, by Type
    • 12.3.10.1.2. Market size and forecast, by Base
    • 12.3.10.1.3. Market size and forecast, by Prescription Type
    • 12.3.10.1.4. Market size and forecast, by Therapeutic Application
    • 12.3.10.1.5. Market size and forecast, by Fill Volume Categories
    • 12.3.10.1.6. Market size and forecast, by Age Group
    • 12.3.10.1.7. Market size and forecast, by Distribution Channel
    • 12.3.10.1.8. Market size and forecast, by End User
    • 12.3.10.2. France
    • 12.3.10.2.1. Market size and forecast, by Type
    • 12.3.10.2.2. Market size and forecast, by Base
    • 12.3.10.2.3. Market size and forecast, by Prescription Type
    • 12.3.10.2.4. Market size and forecast, by Therapeutic Application
    • 12.3.10.2.5. Market size and forecast, by Fill Volume Categories
    • 12.3.10.2.6. Market size and forecast, by Age Group
    • 12.3.10.2.7. Market size and forecast, by Distribution Channel
    • 12.3.10.2.8. Market size and forecast, by End User
    • 12.3.10.3. UK
    • 12.3.10.3.1. Market size and forecast, by Type
    • 12.3.10.3.2. Market size and forecast, by Base
    • 12.3.10.3.3. Market size and forecast, by Prescription Type
    • 12.3.10.3.4. Market size and forecast, by Therapeutic Application
    • 12.3.10.3.5. Market size and forecast, by Fill Volume Categories
    • 12.3.10.3.6. Market size and forecast, by Age Group
    • 12.3.10.3.7. Market size and forecast, by Distribution Channel
    • 12.3.10.3.8. Market size and forecast, by End User
    • 12.3.10.4. Rest of Europe
    • 12.3.10.4.1. Market size and forecast, by Type
    • 12.3.10.4.2. Market size and forecast, by Base
    • 12.3.10.4.3. Market size and forecast, by Prescription Type
    • 12.3.10.4.4. Market size and forecast, by Therapeutic Application
    • 12.3.10.4.5. Market size and forecast, by Fill Volume Categories
    • 12.3.10.4.6. Market size and forecast, by Age Group
    • 12.3.10.4.7. Market size and forecast, by Distribution Channel
    • 12.3.10.4.8. Market size and forecast, by End User
• 12.4. Asia-Pacific
  • 12.4.1. Key market trends, growth factors and opportunities
  • 12.4.2. Market size and forecast, by Type
  • 12.4.3. Market size and forecast, by Base
  • 12.4.4. Market size and forecast, by Prescription Type
  • 12.4.5. Market size and forecast, by Therapeutic Application
  • 12.4.6. Market size and forecast, by Fill Volume Categories
  • 12.4.7. Market size and forecast, by Age Group
  • 12.4.8. Market size and forecast, by Distribution Channel
  • 12.4.9. Market size and forecast, by End User
  • 12.4.10. Market size and forecast, by country
    • 12.4.10.1. Japan
    • 12.4.10.1.1. Market size and forecast, by Type
    • 12.4.10.1.2. Market size and forecast, by Base
    • 12.4.10.1.3. Market size and forecast, by Prescription Type
    • 12.4.10.1.4. Market size and forecast, by Therapeutic Application
    • 12.4.10.1.5. Market size and forecast, by Fill Volume Categories
    • 12.4.10.1.6. Market size and forecast, by Age Group
    • 12.4.10.1.7. Market size and forecast, by Distribution Channel
    • 12.4.10.1.8. Market size and forecast, by End User
    • 12.4.10.2. China
    • 12.4.10.2.1. Market size and forecast, by Type
    • 12.4.10.2.2. Market size and forecast, by Base
    • 12.4.10.2.3. Market size and forecast, by Prescription Type
    • 12.4.10.2.4. Market size and forecast, by Therapeutic Application
    • 12.4.10.2.5. Market size and forecast, by Fill Volume Categories
    • 12.4.10.2.6. Market size and forecast, by Age Group
    • 12.4.10.2.7. Market size and forecast, by Distribution Channel
    • 12.4.10.2.8. Market size and forecast, by End User
    • 12.4.10.3. India
    • 12.4.10.3.1. Market size and forecast, by Type
    • 12.4.10.3.2. Market size and forecast, by Base
    • 12.4.10.3.3. Market size and forecast, by Prescription Type
    • 12.4.10.3.4. Market size and forecast, by Therapeutic Application
    • 12.4.10.3.5. Market size and forecast, by Fill Volume Categories
    • 12.4.10.3.6. Market size and forecast, by Age Group
    • 12.4.10.3.7. Market size and forecast, by Distribution Channel
    • 12.4.10.3.8. Market size and forecast, by End User
    • 12.4.10.4. Rest of Asia-Pacific
    • 12.4.10.4.1. Market size and forecast, by Type
    • 12.4.10.4.2. Market size and forecast, by Base
    • 12.4.10.4.3. Market size and forecast, by Prescription Type
    • 12.4.10.4.4. Market size and forecast, by Therapeutic Application
    • 12.4.10.4.5. Market size and forecast, by Fill Volume Categories
    • 12.4.10.4.6. Market size and forecast, by Age Group
    • 12.4.10.4.7. Market size and forecast, by Distribution Channel
    • 12.4.10.4.8. Market size and forecast, by End User
• 12.5. LAMEA
  • 12.5.1. Key market trends, growth factors and opportunities
  • 12.5.2. Market size and forecast, by Type
  • 12.5.3. Market size and forecast, by Base
  • 12.5.4. Market size and forecast, by Prescription Type
  • 12.5.5. Market size and forecast, by Therapeutic Application
  • 12.5.6. Market size and forecast, by Fill Volume Categories
  • 12.5.7. Market size and forecast, by Age Group
  • 12.5.8. Market size and forecast, by Distribution Channel
  • 12.5.9. Market size and forecast, by End User
  • 12.5.10. Market size and forecast, by country
    • 12.5.10.1. Latin America
    • 12.5.10.1.1. Market size and forecast, by Type
    • 12.5.10.1.2. Market size and forecast, by Base
    • 12.5.10.1.3. Market size and forecast, by Prescription Type
    • 12.5.10.1.4. Market size and forecast, by Therapeutic Application
    • 12.5.10.1.5. Market size and forecast, by Fill Volume Categories
    • 12.5.10.1.6. Market size and forecast, by Age Group
    • 12.5.10.1.7. Market size and forecast, by Distribution Channel
    • 12.5.10.1.8. Market size and forecast, by End User
    • 12.5.10.2. Middle East And Africa
    • 12.5.10.2.1. Market size and forecast, by Type
    • 12.5.10.2.2. Market size and forecast, by Base
    • 12.5.10.2.3. Market size and forecast, by Prescription Type
    • 12.5.10.2.4. Market size and forecast, by Therapeutic Application
    • 12.5.10.2.5. Market size and forecast, by Fill Volume Categories
    • 12.5.10.2.6. Market size and forecast, by Age Group
    • 12.5.10.2.7. Market size and forecast, by Distribution Channel
    • 12.5.10.2.8. Market size and forecast, by End User

CHAPTER 13: COMPETITIVE LANDSCAPE

• 13.1. Introduction
• 13.2. Top winning strategies
• 13.3. Product mapping of top 10 player
• 13.4. Competitive dashboard
• 13.5. Competitive heatmap
• 13.6. Top player positioning, 2023

CHAPTER 14: COMPANY PROFILES

• 14.1. Intas Pharmaceuticals Ltd.
  • 14.1.1. Company overview
  • 14.1.2. Key executives
  • 14.1.3. Company snapshot
  • 14.1.4. Operating business segments
  • 14.1.5. Product portfolio
• 14.2. Pfizer Inc.
  • 14.2.1. Company overview
  • 14.2.2. Key executives
  • 14.2.3. Company snapshot
  • 14.2.4. Operating business segments
  • 14.2.5. Product portfolio
  • 14.2.6. Business performance
• 14.3. Church & Dwight Co. Inc.
  • 14.3.1. Company overview
  • 14.3.2. Key executives
  • 14.3.3. Company snapshot
  • 14.3.4. Operating business segments
  • 14.3.5. Product portfolio
  • 14.3.6. Business performance
• 14.4. Zydus Lifesciences Limited
  • 14.4.1. Company overview
  • 14.4.2. Key executives
  • 14.4.3. Company snapshot
  • 14.4.4. Operating business segments
  • 14.4.5. Product portfolio
  • 14.4.6. Business performance
  • 14.4.7. Key strategic moves and developments
• 14.5. Bayer AG
  • 14.5.1. Company overview
  • 14.5.2. Key executives
  • 14.5.3. Company snapshot
  • 14.5.4. Operating business segments
  • 14.5.5. Product portfolio
  • 14.5.6. Business performance
• 14.6. Novartis AG
  • 14.6.1. Company overview
  • 14.6.2. Key executives
  • 14.6.3. Company snapshot
  • 14.6.4. Operating business segments
  • 14.6.5. Product portfolio
  • 14.6.6. Business performance
• 14.7. Sanofi S.A.
  • 14.7.1. Company overview
  • 14.7.2. Key executives
  • 14.7.3. Company snapshot
  • 14.7.4. Operating business segments
  • 14.7.5. Product portfolio
  • 14.7.6. Business performance
• 14.8. Bliss GVS Pharma Ltd
  • 14.8.1. Company overview
  • 14.8.2. Key executives
  • 14.8.3. Company snapshot
  • 14.8.4. Operating business segments
  • 14.8.5. Product portfolio
  • 14.8.6. Business performance
• 14.9. Bausch Health Companies Inc.
  • 14.9.1. Company overview
  • 14.9.2. Key executives
  • 14.9.3. Company snapshot
  • 14.9.4. Operating business segments
  • 14.9.5. Product portfolio
  • 14.9.6. Business performance
• 14.10. Cosette Pharmaceuticals, Inc.
  • 14.10.1. Company overview
  • 14.10.2. Key executives
  • 14.10.3. Company snapshot
  • 14.10.4. Operating business segments
  • 14.10.5. Product portfolio

관련자료